,title,source,link,date
43,Ivonescimab Challenges Tislelizumab Plus Chemo in Advanced ...,Targeted Oncology,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2l2b25lc2NpbWFiLWNoYWxsZW5nZXMtdGlzbGVsaXp1bWFiLXBsdXMtY2hlbW8taW4tYWR2YW5jZWQtZWdmci1ucy1uc2NsY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
57,Tool helps improve accuracy of focal therapy for prostate cancer,Urology Times,news.google.com/articles/CBMiYmh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy90b29sLWhlbHBzLWltcHJvdmUtYWNjdXJhY3ktb2YtZm9jYWwtdGhlcmFweS1mb3ItcHJvc3RhdGUtY2FuY2Vy0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
39,FDA Accepts sBLA for Amivantamab/Chemo in EGFR Exon 20+ ...,Cancer Network,news.google.com/articles/CBMiX2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZmRhLWFjY2VwdHMtc2JsYS1mb3ItYW1pdmFudGFtYWItY2hlbW8taW4tZWdmci1leG9uLTIwLW5zY2xj0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
36,LEAP-010 Trial Discontinued After OS Projection With ...,OncLive,news.google.com/articles/CBMifmh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvbGVhcC0wMTAtdHJpYWwtZGlzY29udGludWVkLWFmdGVyLW9zLXByb2plY3Rpb24td2l0aC1wZW1icm9saXp1bWFiLWxlbnZhdGluaWItaW4tbWV0YXN0YXRpYy1obnNjY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
35,FDA Clears Investigational New Drug Application to Treat ...,Pharmacy Times,news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZmRhLWNsZWFycy1pbnZlc3RpZ2F0aW9uYWwtbmV3LWRydWctYXBwbGljYXRpb24tdG8tdHJlYXQtYW15b3Ryb3BoaWMtbGF0ZXJhbC1zY2xlcm9zaXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
65,FDA Approves First Biosimilar of Natalizumab for the Treatment of ...,Pharmacy Times,news.google.com/articles/CBMigQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2ZkYS1hcHByb3Zlcy1maXJzdC1iaW9zaW1pbGFyLW9mLW5hdGFsaXp1bWFiLWZvci10aGUtdHJlYXRtZW50LW9mLXJlbGFwc2luZy1tdWx0aXBsZS1zY2xlcm9zaXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
32,Charina Toste Discusses the Educational Obstacles Patients With ...,www.oncnursingnews.com/,news.google.com/articles/CBMibWh0dHBzOi8vd3d3Lm9uY251cnNpbmduZXdzLmNvbS92aWV3L2NoYXJpbmEtdG9zdGUtZGlzY3Vzc2VzLXRoZS1lZHVjYXRpb25hbC1vYnN0YWNsZXMtcGF0aWVudHMtd2l0aC1tcG5zLWZhY2XSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
44,Dara-KRd Quadruplet Makes Waves in Newly Diagnosed Multiple ...,OncLive,news.google.com/articles/CBMiYGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZGFyYS1rcmQtcXVhZHJ1cGxldC1tYWtlcy13YXZlcy1pbi1uZXdseS1kaWFnbm9zZWQtbXVsdGlwbGUtbXllbG9tYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
1,Selpercatinib Elicits Notable PFS Benefit in RET+ Medullary Thyroid ...,Cancer Network,news.google.com/articles/CBMibGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvc2VscGVyY2F0aW5pYi1lbGljaXRzLW5vdGFibGUtcGZzLWJlbmVmaXQtaW4tcmV0LW1lZHVsbGFyeS10aHlyb2lkLWNhbmNlctIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
20,ASCO Reading Room | Immunotherapy for ROS1-Rearranged ...,Medpage Today,news.google.com/articles/CBMiNGh0dHBzOi8vd3d3Lm1lZHBhZ2V0b2RheS5jb20vYXNjby9sdW5nLWNhbmNlci8xMDYwNDDSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
